Connection

Yuri Peterson to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Yuri Peterson has written about Dose-Response Relationship, Drug.
  1. Development of inhibitors of heterotrimeric Gai subunits. Bioorg Med Chem. 2014 Jul 01; 22(13):3423-34.
    View in: PubMed
    Score: 0.087
  2. Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins. J Biol Chem. 2002 Mar 01; 277(9):6767-70.
    View in: PubMed
    Score: 0.037
  3. Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia. J Med Chem. 2016 11 10; 59(21):9942-9959.
    View in: PubMed
    Score: 0.026
  4. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.020
  5. High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2. PLoS One. 2012; 7(9):e44918.
    View in: PubMed
    Score: 0.020
  6. Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2464-71.
    View in: PubMed
    Score: 0.014
  7. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron. 2004 Apr 22; 42(2):269-81.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.